{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:56Z","timestamp":1788922196489,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K99AA027835"],"award-info":[{"award-number":["K99AA027835"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32AA007456"],"award-info":[{"award-number":["T32AA007456"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA026281"],"award-info":[{"award-number":["R01AA026281"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["US20160038559"],"award-info":[{"award-number":["US20160038559"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pbb.2025.174040","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:14:51Z","timestamp":1747941291000},"page":"174040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological and genetic manipulation of glyoxalase-1 (GLO1) does not alter locomotor responses or conditioned place preference induced by cocaine or oxycodone."],"prefix":"10.1016","volume":"253","author":[{"given":"Elizabeth","family":"Alcantara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara A.","family":"Ortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ilustrisimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bloom","family":"Stromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Barkley-Levenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2025.174040_bb0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/acer.13623","article-title":"Glyoxalase 1 (GLO1) inhibition or genetic overexpression does not alter ethanol\u2019s locomotor effects: implications for GLO1 as a therapeutic target in alcohol use disorders","volume":"42","author":"Barkley-Levenson","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pbb.2025.174040_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11010127","article-title":"Genetic and pharmacological manipulations of glyoxalase 1 mediate ethanol withdrawal seizure susceptibility in mice","volume":"11","author":"Barkley-Levenson","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.pbb.2025.174040_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pbb.2018.03.001","article-title":"Inhibition of glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats","volume":"167","author":"de Guglielmo","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174040_bb0020","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI61319","article-title":"Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal","volume":"122","author":"Distler","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbb.2025.174040_bb0025","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pbb.2025.174040_bb0030","series-title":"Differences in Fentanyl-induced Conditioned Place Preference and Open Field Activity in A\/J and B6J Mice; Potential Role for Glyoxalase 1","author":"Harp","year":"2021"},{"key":"10.1016\/j.pbb.2025.174040_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113630","article-title":"Fentanyl-induced acute and conditioned behaviors in two inbred mouse lines: potential role for glyoxalase","volume":"243","author":"Harp","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2025.174040_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105209","article-title":"Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit\/hyperactivity disorder: a substantive and methodological overview","volume":"151","author":"Hartman","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2025.174040_bb0045","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature04250","article-title":"Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice","volume":"438","author":"Hovatta","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2025.174040_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopsych.2013.04.028","article-title":"Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction","volume":"74","author":"Kallupi","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174040_bb0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","article-title":"Oxycodone in the opioid epidemic: high \u201cliking\u201d, \u201cwanting\u201d, and abuse liability","volume":"41","author":"Kibaly","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2025.174040_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/adb.12333","article-title":"Genetic and pharmacological manipulation of glyoxalase 1 regulates voluntary ethanol consumption in mice","volume":"22","author":"McMurray","year":"2017","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.pbb.2025.174040_bb0065","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2017.14","article-title":"Identification of a novel, fast-acting GABAergic antidepressant","volume":"23","author":"McMurray","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174040_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2008.02.010","article-title":"Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine","volume":"90","author":"Morris","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174040_bb0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pbb.2013.06.010","article-title":"Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice","volume":"110","author":"Niikura","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174040_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-2259-6","article-title":"Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL\/6 and DBA\/2 inbred strains","volume":"181","author":"Orsini","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174040_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp053113","article-title":"Mood disorders and substance use disorder: a complex comorbidity","volume":"3","author":"Quello","year":"2005","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.pbb.2025.174040_bb0090","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012195","article-title":"The central amygdala and alcohol: role of \u03b3-aminobutyric acid, glutamate, and neuropeptides","volume":"2","author":"Roberto","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pbb.2025.174040_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1749-6632.2000.tb06680.x","article-title":"GABA modulation of cocaine self-administration","volume":"909","author":"Roberts","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2025.174040_bb0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/jpet.108.150011","article-title":"The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors","volume":"330","author":"Smith","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2025.174040_bb0105","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2023 National Survey on Drug Use and Health. (HHS Publication No. PEP24-07-021, NSDUH Series H-59)","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"10.1016\/j.pbb.2025.174040_bb0110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.neuron.2012.02.016","article-title":"Activation of VTA GABA neurons disrupts reward consumption","volume":"73","author":"van Zessen","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2025.174040_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/37610","article-title":"How opioids inhibit GABA-mediated neurotransmission","volume":"390","author":"Vaughan","year":"1997","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.pbb.2025.174040_bb0120","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/acschemneuro.0c00482","article-title":"Glyoxalase 1 inhibitor alleviates autism-like phenotype in a prenatal valproic acid-induced mouse model","volume":"11","author":"Wang","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2025.174040_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004649","article-title":"A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174040_bb0130","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41593-023-01452-y","article-title":"Single-nucleus genomics in outbred rats with divergent cocaine addiction-like behaviors reveals changes in amygdala GABAergic inhibition","volume":"26","author":"Zhou","year":"2023","journal-title":"Nat. Neurosci."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:31:03Z","timestamp":1778664663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"alternative-id":["S0091305725000875"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174040","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and genetic manipulation of glyoxalase-1 (GLO1) does not alter locomotor responses or conditioned place preference induced by cocaine or oxycodone.","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"174040"}}